France slows COVID vaccine rollout for hospital workers due to “side effects”
Reproduced from original article:
by: Sara Middleton, staff writer | March 5, 2021
(NaturalHealth365) On a webpage about vaccine safety, the U.S. Centers for Disease Control and Prevention (CDC) states that while “clinical trials provide important information on vaccine safety, the data are somewhat limited because of the relatively small number (hundreds to thousands) of study participants. Rare side effects and delayed reactions might not be evident until the vaccine is administered to millions of people.” (Emphasis ours.)
And so, here we are: the experimental COVID-19 vaccine is now being administered to millions of people across the globe, and we are hearing time and again of serious adverse effects that warrant further investigation. And many people – including healthcare providers in select French hospitals – aren’t willing to risk their health by lining up for a jab.
Non merci: French healthcare providers say “No, thank you” to AstraZeneca COVID-19 vaccine due to high rate of side effects
As was the case in other countries, healthcare workers were in the first wave of people in France to receive the investigational, non-FDA-approved COVID-19 vaccine by AstraZeneca. Anticipating the high rate of COVID vaccine side effects from the drugs, many healthcare facilities (including hundreds here in the United States) employed a “staggered” vaccination schedule to prevent entire departments from getting sick at once.
But for many hospitals, even that “precaution” didn’t work.
One report indicates that the university hospital of Brest in Brittany, Western France saw up to 25 percent of its vaccine recipients call out of work due to severe symptoms like headaches, muscle aches, and high fever. Another report notes that the Hygiene and Safety Committee at the hospital in Périgueux, France reported serious adverse effects occurring in up to 70 percent of their recently-vaccinated healthcare workers.
Affected staff members include critical employees like intensive care unit (ICU) nurses and physical therapists. Aside from threatening the staff members’ own comfort and safety, these mass call-outs also led to potentially dangerous staff shortages on ICU and COVID-19 units.
Do NOT ignore the health dangers linked to toxic indoor air. These chemicals – the ‘off-gassing’ of paints, mattresses, carpets and other home/office building materials – increase your risk of nasal congestion, fatigue, poor sleep, skin issues plus many other health issues.
Get the BEST indoor air purification system – at the LOWEST price, exclusively for NaturalHealth365 readers. I, personally use this system in my home AND office. Click HERE to order now – before the sale ends.
In other news: FDA authorizes emergency use of Johnson & Johnson COVID-19 vaccine despite lack of evidence that it prevents spread of coronavirus
The world is taking a big risk on these investigational drugs – drugs that aren’t even proven to work, per the FDA’s own admission.
In their recent news release detailing the emergency use authorization (EUA) for the Johnson & Johnson COVID-19 vaccine (aka Janssen vaccine), the FDA states, “At this time, data are not available to determine how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person.” The same warnings were included in the FDA’s news releases about the Moderna and Pfizer vaccines.
Given the lack of evidence, it’s no wonder Dr. Anthony Fauci and other public health officials continue to demand that even vaccinated citizens continue to abide by pandemic policies, including social distancing and mask-wearing.
Such admission from the FDA is doubly concerning given the alarming news that participants from the Pfizer and Moderna clinical trials are dropping out in order to get the vaccine – meaning these studies are no longer truly “placebo-controlled” and that the ability of these trials to accurately assess long-term vaccine safety outcomes is now seriously threatened.
Of course, these (now-jeopardized) trials are already rife with conflicts of interest. In their official disclosure forms provided by the International Committee of Medical Journal Editors, authors of the phase 3 Moderna trial endorse funding from the likes of the National Institutes of Health (NIH), Fauci-run National Institute of Allergy and Infectious Diseases (NIAID), the Gates Foundation, and several pharmaceutical companies – including Moderna itself.
How far will public officials go with these unproven, mass-administered drugs – and how easily will the public accept continually restrictive policies, including vaccine passports? Time will tell, although in a glimmer of hope more people are asking questions, seeking answers, and speaking out.
Sources for this article include: